Clinical trial • Phase IV • Oncology|Neurology
Temozolomide for Brain stem glioma|Malignant glioma
Phase IV trial of Temozolomide for Brain stem glioma|Malignant glioma. 60 participants.
Overview
- Trial Therapeutic Area
- Oncology|Neurology
- Trial Disease
- Brain stem glioma|Malignant glioma
- Trial Stage
- Phase IV
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 07-06-2024
- First CTIS Authorization Date
- 01-08-2024
Trial design
Phase IV trial across 24 sites in France.
- Target Sample Size
- 60
Eligibility
Recruits 60 No vulnerable populations selected; trial population is adults..
- Vulnerable Population
- No vulnerable populations selected; trial population is adults.
Recruitment
- Planned Sample Size
- 60
- Recruitment Window Months
- 90
Geography
- Total Number Of Sites
- 24
- Total Number Of Participants
- 60
France
- Earliest CTIS Part Ii Submission Date
- 13-06-2024
- Latest Decision Or Authorization Date
- 08-10-2025
- Processing Time Days
- 482
- Number Of Sites
- 24
- Number Of Participants
- 60
Sites
- Site Name
- ICANS - Institut de cancérologie Strasbourg Europe
- Department Name
- RADIOTHÉRAPIE | RADIOISOTOPES | RADIOLOGIE | RADIOPHYSIQUE
- Contact Person Name
- Georges Noël
- Contact Person Email
- g.noel@icans.eu
- Site Name
- CHRU De Nancy
- Department Name
- Neuro-oncologie
- Contact Person Name
- Marie Blonski
- Contact Person Email
- m.blonski@chru-nancy.fr
- Site Name
- Hospital Foch
- Department Name
- Neuroscience
- Contact Person Name
- Nadia Younan
- Contact Person Email
- n.younan@hopital-foch.com
- Site Name
- CHRU de Brest - Hôpital de la cavale Blanche
- Department Name
- Neurochirurgie
- Contact Person Name
- Elsa Magro
- Contact Person Email
- elsa.magro@chu-brest.fr
- Site Name
- Centre Henri Becquerel
- Department Name
- Oncologie Médicale
- Contact Person Name
- Isabelle Tennevet
- Contact Person Email
- isabelle.tennevet@chb.unicancer.fr
- Site Name
- CHU Saint Etienne Hôpital Nord
- Department Name
- NEUROLOGIE
- Contact Person Name
- Carole Ramirez
- Contact Person Email
- Carole.Ramirez@chu-st-etienne.fr
- Site Name
- Centre Hospitalier Et Universitaire De Limoges
- Department Name
- Oncologie Médicale
- Contact Person Name
- Tiffany Farbas
- Contact Person Email
- Tiffany.DARBAS@chu-limoges.fr
- Site Name
- Institut Gustave Roussy
- Department Name
- Onco-radiologie
- Contact Person Name
- Frédéric Dhermain
- Contact Person Email
- Frederic.dhermain@gustaveroussy.fr
- Site Name
- Hospices Civils de LYON - Hôpital Pierre Wertheimer
- Department Name
- Neuro-oncologie
- Contact Person Name
- François Ducray
- Contact Person Email
- francois.ducray@chu-lyon.fr
- Site Name
- Institut Regional Du Cancer De Montpellier
- Department Name
- Oncologie Médicale
- Contact Person Name
- Michel Fabbro
- Contact Person Email
- michel.fabbro@icm.unicancer.fr
- Site Name
- CHU de Nice- Hôpital Pasteur 2
- Department Name
- NEUROLOGIE
- Contact Person Name
- Véronique Bourg
- Contact Person Email
- bourg.v@chu-nice.fr
- Site Name
- Centre De Recherche En Cancerologie De Lyon
- Department Name
- Oncologie Médicale
- Contact Person Name
- Alice Bonneville-Levard
- Contact Person Email
- LEVARD@lyon.unicancer.fr
- Site Name
- Hôpitaux Universitaires de Marseille Timone
- Department Name
- Neuro-oncologie
- Contact Person Name
- Olivier Chinot
- Contact Person Email
- Olivier.CHINOT@ap-hm.fr
- Site Name
- Centre Hospitalier De Colmar
- Department Name
- NEUROLOGIE
- Contact Person Name
- Guido Ahle
- Contact Person Email
- guido.ahle@ch-colmar.fr
- Site Name
- CHU Amiens - Groupe Hospitalier Sud
- Department Name
- Oncologie Médicale et Neurologie
- Contact Person Name
- Mathieu Boone
- Contact Person Email
- boone.mathieu@chu-amiens.fr
- Site Name
- CHU Saint Eloi
- Department Name
- Neurochirurgie
- Contact Person Name
- Luc Bauchet
- Contact Person Email
- l-bauchet@chu-montpellier.fr
- Site Name
- Centre Hospitalier Universitaire Rouen
- Department Name
- Neurochirurgie
- Contact Person Name
- Olivier Langlois
- Contact Person Email
- Olivier.langlois@chu-rouen.fr
- Site Name
- Centre Hospitalier Regional Et Universitaire De Brest
- Department Name
- Oncologie Médicale
- Contact Person Name
- Benjamin Auberger
- Contact Person Email
- benjamin.auberger@chu-brest.fr
- Site Name
- Centre Hospitalier Universitaire De Lille
- Department Name
- Neuro-onclologie
- Contact Person Name
- Apolline Monfilliette
- Contact Person Email
- Apolline.DJELAD@CHRU-LILLE.FR
- Site Name
- CHU Grenoble Alpes - Hôpital Michallon
- Department Name
- Oncologie médicale
- Contact Person Name
- Julien Pavillet
- Contact Person Email
- jpavillet@chu-grenoble.fr
- Site Name
- Institut de Cancérologie de l'Ouest - site d'Angers
- Department Name
- Oncologie Médicale
- Contact Person Name
- Pierre Kubicek
- Contact Person Email
- Pierre.kubicek@ico.unicancer.fr
- Site Name
- Assistance Publique Hopitaux De Paris
- Department Name
- NEUROLOGIE
- Contact Person Name
- Florence Laigle-Donadey
- Contact Person Email
- florence.laigle-donadey@aphp.fr
- Site Name
- CHU Rennes - Hôpital Pontchaillou- Centre Eugène Marquis
- Department Name
- Oncologie Médicale
- Contact Person Name
- Elodie Vauleon
- Contact Person Email
- e.vauleon@rennes.unicancer.fr
- Site Name
- Centre de Coordination en Cancérologie François Baclesse
- Department Name
- Neur-onclologie
- Contact Person Name
- Ioana HRAB
- Contact Person Email
- i.hrab@baclesse.unicancer.fr
Sponsor
Primary sponsor
- Full Name
- Assistance Publique Hopitaux De Paris
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- Temozolomide
- Active Substance
- Temozolomide
- Modality
- Small molecule
Related trials
Other published trials that may interest you.
- Zoledronic acid monohydrate for Glioblastoma
- melflufen for Recurrent glioblastoma|Glioblastoma
- 7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE HYDROCHLORIDE for Medulloblastoma (recurrent or progressive)
- tirabrutinib for Primary central nervous system lymphoma (PCNSL) | B-cell primary central nervous system lymphoma (relapsed/refractory)
- TEMOZOLOMIDE for Diffuse Midline Glioma, H3K27-altered